| Name | 5'-O-(4,4'-Dimethoxytrityl)-N4-acetyl-2'-deoxycytidine |
|---|---|
| Synonyms |
N-Acetyl-5′-O-[bis(4-methoxyphenyl)phenylmethyl]cytidine
n-acetyl-5'-dmt deoxycytidine DMT-NAC-DC N-[1-[(2R,3R,4S,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-3,4-dihydroxyoxolan-2-yl]-2-oxopyrimidin-4-yl]acetamide N4-Acetyl-5'-O-(4,4'-dimethoxytrityl)-2'-deoxycytidine N-ACETYL-5'-DMT DEOXYCYTIDINE 5'-O-DMT-N4-Ac cytidine DMT-rC(Ac) N4-ACETYL-5'-(DIMETHOXYTRITYL)-2'-DEOXYCYTIDINE dmt-nac-dc Cytidine, N-acetyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl] 5'-O-(4,4'-DiMethoxytrityl)-N4-acetyl cytidine 5’-O-DMTr-Cytidine (N-Ac) DTN-003 5'-O-(4,4'-DiMethoxytrityl)-N4-Acetyl-2'-Deoxycytidine N4-acetyl-5'-0-(4, 4-dimethoxytrityl)-cytidine N-(1-((2R,3R,4S,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3,4-dihydroxytetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)acetamide |
| Description | N4-Acetyl-5’-O-(4,4’-dimethoxytrityl)-2’-deoxycytidine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.32±0.1 g/cm3(Predicted) |
|---|---|
| Molecular Formula | C32H33N3O7 |
| Molecular Weight | 571.62 |
| Exact Mass | 587.22700 |
| PSA | 141.37000 |
| LogP | 2.91980 |
|
~63%
121058-82-0 |
| Literature: Reddy, M. P.; Farooqui, Firdous; Hanna, Naeem B. Tetrahedron Letters, 1995 , vol. 36, # 49 p. 8929 - 8932 |
|
~72%
121058-82-0 |
| Literature: Pitsch, Stefan; Weiss, Patrick A.; Jenny, Luzi; Stutz, Alfred; Wu, Xiaolin Helvetica Chimica Acta, 2001 , vol. 84, # 12 p. 3773 - 3795 |
|
~%
121058-82-0 |
| Literature: Tetrahedron Letters, , vol. 39, # 14 p. 1897 - 1900 |
|
~%
121058-82-0 |
| Literature: Tetrahedron Letters, , vol. 30, # 1 p. 71 - 74 |